UNSPSC 51111774: Vorinostat

This classification denotes a histone deacetylase inhibitor with the molecular formula C14H20N2O3, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier 58IFB293JI, chemically known as saha, suberoylanilide hydroxamic acid but generally known as vorinostat, which bears US NIH Compound Identifier 5311. European Medicines Agency schedules Vorinostat in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB23356.

UNSPSC 51111774 Vorinostat is a Commodity code for pharmaceutical products, but recent state and local procurement activity under this code does not reflect purchases of vorinostat itself. Instead, the posted opportunities show state and local governments procuring other pharmaceutical products and health-related supplies through piggyback contracts and direct competitive bids — including antibiotics (doxycycline, ciprofloxacin), emergency medical supplies (naloxone), and drug deactivation systems. The issuing bodies include state departments of public health and county government agencies focused on community health and emergency response.

Activity appears concentrated in Florida and Illinois. The Illinois Department of Public Health awarded a $2,999,999.11 piggyback contract through the MMCAP Infuse cooperative purchasing consortium to Chartwell Rx LLC in August 2026 for a 12-month term with two renewal options, procuring antibiotic tablets. Seminole County, Florida released an IFB (Invitation for Bid) on June 30, 2026, seeking annual procurement of 1,900 units of naloxone and 800 safe drug deactivation systems with quarterly deliveries and a two-year initial term plus one-year renewal option. The mismatch between the code's nominal scope and actual recent procurement activity suggests this code may see limited direct application for vorinostat purchases in state and local markets, or that opportunities under this code are tagged inconsistently with their actual pharmaceutical content.